XALOX RTU oxaliplatin 50mg/10mL concentrated solution for injection vial

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

oxaliplatin, Quantity: 50 mg

MAH:

Medis Pharma Pty Ltd

INN:

Oxaliplatin

pharmaceutical_form:

Injection, concentrated

composition:

Excipient Ingredients: lactose monohydrate; water for injections

administration_route:

Intravenous Infusion

units_in_package:

1 vial

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: ,? Adjuvant treatment of stage III (Duke?s C) colon cancer after complete resection of ,the primary tumour ,? Treatment of advanced colorectal cancer

leaflet_short:

Visual Identification: Clear, colourless to slightly yellow solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2011-12-12